# Commission Implementing Regulation (EU) 2018/523 of 28 March 2018 amending Regulation (EU) No 37/2010 to classify the substance fluazuron as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘fluazuron’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRLs
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Fluazuron
Fluazuron
All ruminants except bovine and ovine
200 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption
Antiparasitic agents/Agents (acting) against ectoparasites’
7 000 μg/kg
Fat
500 μg/kg
Liver
500 μg/kg
Kidney
Bovine
200 μg/kg
Muscle
NO ENTRY
7 000 μg/kg
Fat
500 μg/kg
Liver
500 μg/kg
Kidney
200 μg/kg
Milk
Fin fish
200 μg/kg
Muscle and skin in natural proportions
NO ENTRY

---
Source: https://www.legislation.gov.uk/eur/2018/523/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-523/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

